Sandu Pharmaceuticals Limited

SANDUPHQ6

INE751D01014

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 11:43:10 15/07/2024 am IST			5-day change	1st Jan Change
60.11 ^INR	-0.56%		-5.70%	-11.73%

05/06	Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
05/06	Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Sandu Pharmaceuticals Limited Appoints Shubhada P. Sandu as Woman Director

April 22, 2015

Sandu Pharmaceuticals Ltd has announced that the board of directors of the company at its meeting held on March 30, 2015, has appointed Dr. Mrs. Shubhada P. Sandu as the woman director of the company with effect from April 01, 2015.

Latest news about Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05/06	CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05/06	CI
Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer	30/03	CI
Sandu Pharmaceuticals Limited Announces Executive Changes	30/03	CI
Sandu Pharmaceuticals Board Mulls CFO Appointment	20/03	MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Sandu Pharmaceuticals CFO to Step Down in December	22/11	MT
Sandu Pharmaceuticals Limited Announces CFO Changes	22/11	CI
Sandu Pharmaceuticals' Consolidated Net Profit Slips in Fiscal Q2	14/11	MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	13/11	CI
Sandu Pharmaceuticals Limited Approves Change in Directorate	30/23/30	CI
Sandu Pharmaceuticals Shuts Goa, India Plant for Renovation	18/23/18	MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023	06/23/06	CI
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31St March 2023	14/23/14	CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/23/14	CI
Sandu Pharmaceuticals Expands Partnership with Vietnam's Bach Ma Van Xuan; Shares Jump 3%	12/22/12	MT
Sandu Pharmaceuticals Limited Enters into Memorandum of Understanding with Bach Ma Van Xuan Pharmaceuticals	10/22/10	CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI
Sandu Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022	01/22/01	CI
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31 March 2022	12/22/12	CI
Sandu Pharmaceuticals Forms New Subsidiary for Phytoceuticals Products	28/22/28	MT
Sandu Pharmaceuticals Limited Incorporates Subsidiary	27/22/27	CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	30/22/30	CI
Sandu Pharmaceuticals Plans New Phytoceutical Product Subsidiary	15/22/15	MT
Sandu Pharmaceuticals Limited Announces Formation of A Wholly Owned Subsidiary Company	14/22/14	CI

Chart Sandu Pharmaceuticals Limited

Duration

Period

More charts

Company Profile

Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
SANDU PHARMACEUTICALS LIMITED	-11.73%	6.99M
DONG-E-E-JIAO CO.,LTD.	+12.92%	4.95B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-32.29%	3.6B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-4.28%	3.03B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.21%	2.66B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-8.82%	2.34B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+39.33%	1.85B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+40.81%	1.45B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-14.27%	1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+41.90%	1.38B